MENU

PTCT PTC Therapeutics Forecast, Technical & Fundamental Analysis

a developer of biopharmaceutical products

Industry Biotechnology
PTCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
PTCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PTCT is expected to report earnings to fall 32.63% to -93 cents per share on February 25

PTC Therapeutics PTCT Stock Earnings Reports
Q4'24
Est.
$-0.94
Q3'24
Beat
by $0.12
Q2'24
Missed
by $0.17
Q1'24
Beat
by $0.09
Q4'23
Missed
by $1.92
The last earnings report on November 07 showed earnings per share of -138 cents, beating the estimate of -150 cents. With 216.93K shares outstanding, the current market capitalization sits at 3.73B.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
100 Corporate Court
Phone
+1 908 222-7000
Employees
1058
Web
https://www.ptcbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VIGAX219.723.62
+1.68%
Vanguard Growth Index Admiral
LMPEX26.120.22
+0.85%
Franklin Global Equity 1
FREIX35.230.02
+0.06%
Franklin Equity Income R
JIAIX9.30N/A
N/A
JHancock Multi-Asset High Income I
CISMX15.19-0.01
-0.07%
Clarkston Partners Institutional

PTCT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PTCT has been loosely correlated with NTLA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PTCT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCT
1D Price
Change %
PTCT100%
-0.64%
NTLA - PTCT
40%
Loosely correlated
-4.21%
ERAS - PTCT
39%
Loosely correlated
-6.08%
PRME - PTCT
38%
Loosely correlated
-1.86%
XNCR - PTCT
38%
Loosely correlated
-0.12%
DYN - PTCT
37%
Loosely correlated
-3.04%
More